Systemic availability and lung deposition of budesonide via three different nebulizers in adults
- 28 February 2003
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 90 (2) , 226-232
- https://doi.org/10.1016/s1081-1206(10)62146-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2002
- Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®British Journal of Clinical Pharmacology, 2001
- Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjectsThorax, 2001
- The Influence of Lung Deposition on Clinical ResponseJournal of Aerosol Medicine, 2001
- Breath-Synchronized Nebulization Diminishes the Impact of Patient-Device Interfaces (Face Mask or Mouthpiece) on the Inhaled Mass of Nebulized BudesonideJournal of Asthma, 2000
- Lung deposition of budesonide in asthmatics: a comparison of different formulationsInternational Journal of Pharmaceutics, 1998
- New perspectives on inhaled drug delivery and systemic bioactivity.Thorax, 1995
- Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDIEuropean Respiratory Journal, 1994
- Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjectsEuropean Respiratory Journal, 1994
- Determination of (22R,S)budesonide in human plasma by automated liquid chromatography/thermospray mass spectrometryJournal of Mass Spectrometry, 1992